agilon health inc. (AGL)
AGL trades on NYSE in Health Care, Misc Health and Biotechnology Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$85.90
+0.48% on the day
Market cap
$1.4B
Small cap
Revenue · 2025
$5.9B
-2.1% on 2024
Net income · 2025
-$391.3M
-6.6% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | AGL on NYSE |
| Sector | Health Care |
| Industry | Misc Health and Biotechnology Services |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001831097 |
| SEC industry code | Services-Misc Health & Allied Services, NEC |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $5.9B |
| Net income | -$391.3M |
| Operating income | -$463.2M |
| Net margin | -6.6% |
| Operating margin | -7.8% |
| Revenue growth | -2.1% |
| Cash | $173.7M |
| Total assets | $1.3B |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.2× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM 424(B)(7) | 424B7 | 2023-05-17 |
| Latest annual report | 10-K | 2026-02-25 |
| Latest quarterly / interim | 10-Q | 2026-08-05 |
| Latest current report | 8-K | 2026-08-05 |
| Latest proxy | DEFA14A | 2026-04-27 |
Source: SEC EDGAR submissions feed, 430 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +0.5% |
| 1 month | -6.5% |
| 3 months | -29.0% |
| Year to date | +399.8% |
| 1 year | +286.5% |
| From 52-week high | -33.7% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Misc Health and Biotechnology Services
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| PGNY | Progyny Inc. | $27.39 | -2.28% | $2.1B |
| SHC | Sotera Health Company | $18.21 | +0.33% | $5.2B |
| VMD | Viemed Healthcare Inc. Common Shares | $9.61 | +0.10% | $366.0M |
| DVA | DaVita Inc. | $182.08 | +0.17% | $11.6B |
| FMS | Fresenius Medical Care AG | $21.08 | -0.61% | $11.8B |
| PARK | Park Dental Partners Inc. | $19.59 | -3.31% | $93.2M |
| CCEL | Cryo-Cell International Inc. | $4.30 | -4.44% | $34.7M |
| MGRX | Mangoceuticals Inc. | $0.3716 | -3.08% | $8.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier